Inicio › Dermatitis atópica (eccema) › South Carolina
Ensayos clínicos de Dermatitis atópica (eccema) en South Carolina
10 estudios sobre Dermatitis atópica (eccema) buscan participantes en South Carolina.
Ciudades en South Carolina
Texto oficial del estudio (inglés)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004, Spartanburg
ReclutandoEstudio observacional
Edades de 12 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07290803First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- National Allergy and Asthma Research, LLC, North Charleston
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07527923A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Medical University of South Carolina - South Carolina Translational Research Nexus Clinic, Charleston
- Tribe Clinical Research, LLC, Greenville
ReclutandoFase 3
Edades de 2 a 11 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06807281A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07003425A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 12, Anderson
ReclutandoFase 2
Edades de 18 a 74 · Todos los sexos · Actualizado el 12 ago 2026 · NCT07037901A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Medical University of South Carolina /ID# 265113, Charleston
ReclutandoFase 3
Edades de 2 a 11 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Charleston
ReclutandoFase 3
6 Months – 11 Years · Todos los sexos · Actualizado el 7 jul 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Medical University of South Carolina /ID# 263655, Charleston
- Advanced Dermatology And Cosmetic Surgery - Spartanburg /ID# 267185, Spartanburg
ReclutandoFase 3
Edades de 18 a 63 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- National Allergy and Asthma, North Charleston
- Spartanburg Medical Research, Spartanburg
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 may 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7106, Bluffton
ReclutandoEstudio observacional
Edades de 12 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT06988605De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.